Latest filing published 03 Jul 2017 for Navidea Biopharmaceuticals, INC., €9,252.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
William J. Regan: trading record in brief
William J. Regan appears in our data through filings on Navidea Biopharmaceuticals, Inc. shares, published by SEC (Form 4). The record holds 7 filings, for trades running from 15 March 2013 to 29 June 2017.
The open-market record is one-sided, with 5 purchases worth €25k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 share grants. So far in 2017, the count stands at 1 purchase and no sales.
The median purchase comes to €4,574.
On 3 July 2017 came the latest disclosure, an open-market purchase for €9,252 in Navidea Biopharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to William J. Regan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ US$0.529319.5% of flowCommon StockSEC:0001437749-17-012172:0Canonical exit: 27 Sept 2017 (T+90)
- 79,155 shares@ US$0.5280.5% of flowNAVB Common Stock, $.001 par valueSEC:0001144204-17-006949:0
- 20,000 shares0Common StockSEC:0001144204-14-073307:0
- 4,400 shares@ US$1.43Common StockSEC:0001225208-14-013102:0Canonical exit: 10 Aug 2014 (T+90)
- 500 shares@ US$1.43Common StockSEC:0001225208-14-013102:1Canonical exit: 10 Aug 2014 (T+90)
- 100 shares@ US$1.43Common StockSEC:0001225208-14-013102:2Canonical exit: 10 Aug 2014 (T+90)
- 5,000 shares@ US$2.71Common StockSEC:0001144204-13-015638:0Canonical exit: 13 Jun 2013 (T+90)
7 of 7 declarations